Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $577.33 | 22 | 87.7% |
| Education | $80.99 | 1 | 12.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $155.86 | 4 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $134.59 | 6 | $0 (2024) |
| ITI, Inc. | $109.28 | 1 | $0 (2023) |
| Alkermes, Inc. | $96.32 | 4 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $84.80 | 4 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $40.18 | 2 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $25.91 | 1 | $0 (2024) |
| AbbVie Inc. | $11.38 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $133.53 | 5 | Neurocrine Biosciences, Inc. ($59.49) |
| 2023 | $362.15 | 9 | Janssen Pharmaceuticals, Inc ($114.23) |
| 2022 | $151.26 | 8 | Neurocrine Biosciences, Inc. ($49.36) |
| 2021 | $11.38 | 1 | AbbVie Inc. ($11.38) |
All Payment Transactions
23 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $25.91 | General |
| Category: Psychiatry/Psychology | ||||||
| 09/24/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $33.76 | General |
| Category: Neuropsychiatry | ||||||
| 03/19/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $25.59 | General |
| Category: Neuroscience | ||||||
| 02/13/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $22.54 | General |
| Category: PSYCHIATRY | ||||||
| 01/16/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $25.73 | General |
| Category: Neuropsychiatry | ||||||
| 09/19/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $25.74 | General |
| Category: Neuropsychiatry | ||||||
| 08/30/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $109.28 | General |
| Category: PSYCHIATRY | ||||||
| 08/26/2023 | Alkermes, Inc. | Vivitrol (Drug) | Food and Beverage | In-kind items and services | $29.16 | General |
| Category: CNS | ||||||
| 08/16/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: Central Nervous System | ||||||
| 07/18/2023 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $25.24 | General |
| Category: Neurology | ||||||
| 06/20/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: CNS | ||||||
| 05/23/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $33.24 | General |
| Category: Neuroscience | ||||||
| 05/12/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Education | In-kind items and services | $80.99 | General |
| Category: Neuroscience | ||||||
| 01/25/2023 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: Central Nervous System | ||||||
| 10/27/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $21.36 | General |
| Category: Neuropsychiatry | ||||||
| 10/17/2022 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: PSYCHIATRY | ||||||
| 09/28/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $23.02 | General |
| Category: Central Nervous System | ||||||
| 08/31/2022 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA INITIO | Food and Beverage | In-kind items and services | $23.50 | General |
| Category: CNS | ||||||
| 06/16/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $11.78 | General |
| Category: Neuropsychiatry | ||||||
| 04/19/2022 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: Neuroscience | ||||||
| 03/24/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: Neuropsychiatry | ||||||
| 02/09/2022 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA INITIO | Food and Beverage | In-kind items and services | $21.70 | General |
| Category: CNS | ||||||
| 02/09/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.38 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 31 | 104 | $6,538 | $2,549 |
| 2022 | 2 | 35 | 111 | $6,815 | $2,585 |
| 2021 | 3 | 74 | 212 | $16,510 | $7,081 |
| 2020 | 3 | 103 | 193 | $11,640 | $4,820 |
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 15 | 51 | $4,948 | $1,630 | 32.9% |
| Q3014 | Telehealth originating site facility fee | Office | 2023 | 16 | 53 | $1,590 | $919.26 | 57.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 17 | 52 | $5,045 | $1,657 | 32.9% |
| Q3014 | Telehealth originating site facility fee | Office | 2022 | 18 | 59 | $1,770 | $928.08 | 52.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 29 | 82 | $11,136 | $4,533 | 40.7% |
| Q3014 | Telehealth originating site facility fee | Office | 2021 | 31 | 108 | $3,240 | $1,910 | 58.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 14 | 22 | $2,134 | $637.82 | 29.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 27 | 47 | $3,364 | $1,461 | 43.4% |
| Q3014 | Telehealth originating site facility fee | Office | 2020 | 30 | 75 | $2,250 | $1,433 | 63.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 16 | 25 | $2,618 | $1,148 | 43.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 30 | 46 | $3,408 | $778.33 | 22.8% |
About Parul Bakshi, APRN
Parul Bakshi, APRN is a Registered Nurse healthcare provider based in Lawrenceville, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/04/2011. The National Provider Identifier (NPI) number assigned to this provider is 1831481241.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Parul Bakshi, APRN has received a total of $658.32 in payments from pharmaceutical and medical device companies, with $133.53 received in 2024. These payments were reported across 23 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($577.33).
As a Medicare-enrolled provider, Bakshi has provided services to 243 Medicare beneficiaries, totaling 620 services with total Medicare billing of $17,036. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.
Practice Information
- Specialty Registered Nurse
- Other Specialties Psychiatric/Mental Health
- Location Lawrenceville, GA
- Active Since 05/04/2011
- Last Updated 12/11/2018
- Taxonomy Code 163W00000X
- Entity Type Individual
- NPI Number 1831481241
Products in Payments
- INVEGA SUSTENNA (Drug) $155.86
- INGREZZA (Drug) $134.59
- CAPLYTA (Drug) $109.28
- ARISTADA (Drug) $67.16
- AUSTEDO (Drug) $41.20
- REXULTI (Drug) $40.18
- Vivitrol (Drug) $29.16
- COBENFY (Drug) $25.91
- UZEDY (Drug) $25.24
- Austedo XR (Drug) $18.36
- VRAYLAR (Drug) $11.38
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Registered Nurse Doctors in Lawrenceville
Glory Osadiaye, Pmhnp, Msn, Bsn, Rn, PMHNP, MSN, BSN, RN
Registered Nurse — Payments: $815.03
Rebecca Booker, Pmhnp, PMHNP
Registered Nurse — Payments: $609.53
Lauren Brooks, Cnp, CNP
Registered Nurse — Payments: $593.53
Rachelle Schultes
Registered Nurse — Payments: $322.30
Mrs. Kimberley Cole, Aprn, APRN
Registered Nurse — Payments: $237.99
Eme Unanaowo, Rn, Np, RN, NP
Registered Nurse — Payments: $220.45